Evogene Ltd
EVGN1.080USD
-0.020-1.82%
收盤 02/06, 16:00（美東）報價延遲15分鐘
9.41M總市值
虧損本益比TTM
關於 Evogene Ltd 公司
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Evogene Ltd簡介
公司代碼EVGN
公司名稱Evogene Ltd
上市日期Jun 11, 2007
CEOEmber (Brian)
員工數量117
證券類型Ordinary Share
年結日Jun 11
公司地址13 Gad Feinstein Street
城市REHOVOT
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編7638517
電話97289311900
網址https://evogene.com/
公司代碼EVGN
上市日期Jun 11, 2007
CEOEmber (Brian)
Evogene Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Mark Kapel
Mr. Mark Kapel
Executive Vice President - Technology
Executive Vice President - Technology
--
--
Mr. Ziv Kop
Mr. Ziv Kop
Independent Director
Independent Director
--
--
Prof. Adrian Percy
Prof. Adrian Percy
Independent Director
Independent Director
--
--
Dr. Elran Hilel Haber
Dr. Elran Hilel Haber
Chief Executive Officer of Biomica Limited
Chief Executive Officer of Biomica Limited
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
收入明細
單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2024
FY2018
由於公司未披露，未能獲取相關數據
地區USD
名稱
營收
佔比
Other
4.00M
47.00%
United States
3.92M
46.00%
Israel
595.77K
7.00%
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 2月1日 週日
更新時間: 2月1日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Recanati (Leon Yehuda)
0.96%
Citadel Advisors LLC
0.66%
Jane Street Capital, L.L.C.
0.45%
Morgan Stanley & Co. LLC
0.35%
Two Sigma Investments, LP
0.13%
其他
97.45%
持股股東
持股股東
佔比
Recanati (Leon Yehuda)
0.96%
Citadel Advisors LLC
0.66%
Jane Street Capital, L.L.C.
0.45%
Morgan Stanley & Co. LLC
0.35%
Two Sigma Investments, LP
0.13%
其他
97.45%
股東類型
持股股東
佔比
Individual Investor
0.96%
Research Firm
0.94%
Hedge Fund
0.79%
Investment Advisor/Hedge Fund
0.17%
Investment Advisor
0.14%
其他
97.00%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
51
144.62K
9.61%
--
2025Q3
53
144.62K
9.93%
--
2025Q2
54
144.62K
9.94%
-290.86K
2025Q1
54
436.41K
15.76%
-409.22K
2024Q4
55
411.93K
12.75%
-150.59K
2024Q3
55
562.52K
10.21%
+159.81K
2024Q2
56
414.42K
108.89%
-12.34K
2024Q1
61
426.75K
10.84%
-122.17K
2023Q4
68
460.98K
18.51%
-27.27K
2023Q3
74
506.57K
13.57%
+395.44K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Recanati (Leon Yehuda)
83.89K
0.96%
--
--
Mar 17, 2025
Citadel Advisors LLC
57.58K
0.66%
+36.21K
+169.43%
Sep 30, 2025
Jane Street Capital, L.L.C.
39.42K
0.45%
+24.40K
+162.42%
Sep 30, 2025
Morgan Stanley & Co. LLC
30.32K
0.35%
+15.16K
+99.95%
Sep 30, 2025
Two Sigma Investments, LP
11.41K
0.13%
-9.68K
-45.91%
Sep 30, 2025
BNP Paribas Securities Corp. North America
11.23K
0.13%
-2.89K
-20.45%
Sep 30, 2025
P&S Vermögensberatungs AG Performance & Sicherheit
10.00K
0.11%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
4.20K
0.05%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
1.20K
0.01%
-5.53K
-82.15%
Sep 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
公告日期
除權除息日
類型
比率
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
